STING ligands in PDAC can affect both cancer cells and TILs, influencing the production of inflammatory cytokines and type I interferons (IFN-α, -β) leading to the facilitation of adaptive immune responses to destroy the tumor cells [140,143,144]. Here, STING1 is linked to neoplasm.